https://www.relativityinvest.ai/company/LSTA/management
Lisata Therapeutics, Inc. (LSTA) - Management | Relativity Invest
View management team score, peer comparison, and insider ownership details for Lisata Therapeutics, Inc. (LSTA). Analyze executive alignment and investment...
lisata therapeuticsinclstamanagementrelativity
https://industryreportmacao.com/article/864307898-lisata-therapeutics-highlights-positive-preclinical-data-of-certepetide-as-part-of-antibody-drug-conjugate-combinations-as-reported-by-licensing
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug...
Industry Report Macao is an online news publication focusing on industries in the Macao: Informing on industries and services news in Macao
lisata therapeuticshighlightspositivepreclinicaldata
https://www.chemdiv.com/company/media/pharma-news/2024/lisata-therapeutics-clinches-rare-disease-status-for-osteosarcoma-drug/
Lisata Therapeutics clinches rare disease status for osteosarcoma drug
Lisata Therapeutics clinches rare disease status for osteosarcoma drug
lisata therapeuticsrare diseaseclinchesstatusosteosarcoma
https://www.lisata.com/product-development-pipeline/diabetic-kidney-disease-dkd-lsta201/
LSTA201 - Diabetic Kidney Disease: Chronic Kidney Disease and Type 2 Diabetes | Lisata
Feb 14, 2025 - LSTA201 is a CD34+ investigational product being studied for the treatment of patients with chronic kidney disease and Type 2 diabetes, also known as diabetic...
diabetic kidney diseasechronictypediabeteslisata